Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism - the Find-AF 2 study - Find-AF 2

niversität Leipzig0 个研究点目标入组 5,200 人开始时间: 2020年6月17日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Recent symptomatic ischemic stroke (sudden focal neurologic deficit lasting > 24h consistent with the territory of a cerebral artery) and/or a corresponding lesion on brain imaging within the last 30 days
•2. Age = 60 years
•3. Patient without or with only slight disability (modified Rankin Scale score = 2) before onset of stroke-related symptoms.
•4. Written informed consent

•1. Known history of atrial fibrillation/flutter or atrial fibrillation/flutter on admission ECG
•2. Current indication for oral anticoagulation at randomisation
•3. Intracerebral bleeding in medical history
•4. Patient scheduled for ECG-monitoring lasting > 7 days (Holter-ECG, implanted loop recorder, etc.)
•5. Implanted pacemaker device or cardioverter/defibrillator or implanted cardiac monitor
•6. Patient not willing to be treated with oral anticoagulants
•7. Carotid artery stenosis ipsilateral to the current ischemic stroke needing operation or intervention.
•8. History of carotid endarterectomy or percutaneous intervention of cerebral artery within the last 30 days.
•9. Life expectancy <1 year for reasons other than stroke (e.g. metastatic cancer)
•10. patients under legal supervision or guardianship
•11. psychological/mental or other inabilities to supply required information (e.g. fill out the questionnaire due to dementia, language difficulties) or participate in the required tests
•12. participation in other randomised interventional trials
•13. suspected lack of compliance

发起方

niversität Leipzig